Olanzapine Injection, Powder, For Solution
Product Images NDC 39822-1800

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 39822-1800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xgen Pharmaceuticals Djb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olz-label (K5756 01 Label For Olanzapine Injection Usp 10mg 20250723)

Label for Olanzapine Injection 10 mg/2 mL single-dose vial by XGen Pharmaceuticals DJB, Inc. Intended for intramuscular use, sterile, with instructions for dosing, reconstitution, and administration method. Includes NDC 39822-1800-1 and manufacturer details (UGI Pharma Inc).*

FDA Label Image

Olz-cm (M5756 01 Carton For Olanzapine Injection Usp 10mg 20250722)

Packaging label for Olanzapine injection, powder for solution, 10 mg per vial, by XGen Pharmaceuticals DJB, Inc. The label includes the NDC 39822-1800-1 and specifies a single-dose vial for intramuscular use only. It also lists inactive ingredients and storage instructions prior to and after reconstitution, with a barcode and trademark.*

FDA Label Image

Structure (Olanzapine 01)

Chemical structure of Olanzapine, showing its molecular framework with nitrogen, sulfur, and methyl groups arranged in a heterocyclic system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.